Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2006-003385-34Phase 3Active
Phase 3, single-arm trial of tiotropium in asthma, sponsored by Boehringer Ingelheim. Primary endpoint: M/P ratio at 40% fall in V'40P. Started Sep 2006; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2006-003385-34.